SDIC
REGN icon

South Dakota Investment Council’s Regeneron Pharmaceuticals REGN Stock Holding History

South Dakota Investment Council’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.09M Buy
14,578
+2,416
+20% +$1.64M 0.16% 136
2026
Q1 		$9.4M Sell
12,162
-800
-6% -$612K 0.18% 113
2025
Q4 		$10M Buy
12,962
+160
+1% +$109K 0.19% 109
2025
Q3 		$7.2M Buy
12,802
+2,683
+27% +$1.52M 0.14% 146
2025
Q2 		$5.31M Buy
10,119
+7,769
+331% +$4.34M 0.1% 189
2025
Q1 		$1.49M Buy
+2,350
New +$1.62M 0.03% 348
2023
Q3 		– Sell
-493
Closed -$354K – 628
2023
Q2 		$354K Sell
493
-100
-17% -$77.1K 0.01% 560
2023
Q1 		$487K Hold
593
– – 0.01% 537
2022
Q4 		$428K Sell
593
-101
-15% -$74.5K 0.01% 546
2022
Q3 		$478K Hold
694
– – 0.01% 527
2022
Q2 		$410K Hold
694
– – 0.01% 540
2022
Q1 		$485K Sell
694
-330
-32% -$209K 0.01% 518
2021
Q4 		$647K Sell
1,024
-800
-44% -$492K 0.01% 519
2021
Q3 		$1.1M Hold
1,824
– – 0.02% 450
2021
Q2 		$1.02M Sell
1,824
-650
-26% -$329K 0.02% 468
2021
Q1 		$1.17M Sell
2,474
-510
-17% -$248K 0.02% 461
2020
Q4 		$1.44M Sell
2,984
-300
-9% -$162K 0.03% 387
2020
Q3 		$1.84M Sell
3,284
-900
-22% -$546K 0.04% 321
2020
Q2 		$2.61M Sell
4,184
-450
-10% -$255K 0.06% 250
2020
Q1 		$2.26M Sell
4,634
-1,676
-27% -$691K 0.06% 240
2019
Q4 		$2.37M Sell
6,310
-320
-5% -$108K 0.05% 289
2019
Q3 		$1.84M Buy
6,630
+480
+8% +$142K 0.04% 358
2019
Q2 		$1.93M Buy
6,150
+2,275
+59% +$757K 0.04% 321
2019
Q1 		$1.59M Buy
3,875
+200
+5% +$82.4K 0.03% 356
2018
Q4 		$1.37M Hold
3,675
– – 0.03% 329
2018
Q3 		$1.49M Sell
3,675
-13,565
-79% -$5.16M 0.03% 357
2018
Q2 		$5.95M Buy
17,240
+13,940
+422% +$4.36M 0.13% 145
2018
Q1 		$1.14M Buy
+3,300
New +$1.15M 0.03% 402

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

South Dakota Investment Council's REGN Position: Q2 2026 in Review

South Dakota Investment Council increased its Regeneron Pharmaceuticals (REGN) stake by 20% in Q2 2026, buying an estimated $1.64M and bringing the position to 14,578 shares worth $9.09M. The position accounts for 0.16% of the portfolio, ranked #136.

South Dakota Investment Council first reported a position in REGN in Q1 2018 and has held it in 28 quarters since. The position peaked at $10M in Q4 2025. 1,333 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • South Dakota Investment Council held 14,578 shares of Regeneron Pharmaceuticals worth $9.09M as of Q2 2026.
  • South Dakota Investment Council bought 2,416 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $1.64M.
  • Regeneron Pharmaceuticals made up 0.16% of South Dakota Investment Council's portfolio in Q2 2026, its #136 holding.
  • South Dakota Investment Council first reported a position in Regeneron Pharmaceuticals in Q1 2018 and has held it in 28 quarters since.
  • South Dakota Investment Council's Regeneron Pharmaceuticals position peaked at $10M in Q4 2025.
  • 1,333 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on South Dakota Investment Council's 13F filing for Q2 2026, filed 11 Aug 2026.